Dna sequencing with non-fluorescent nucleotide reversible terminators and cleavable label modified nucleotide terminators
US-2016024574-A1 · Jan 28, 2016 · US
US10669582B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10669582-B2 |
| Application number | US-201815915983-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 8, 2018 |
| Priority date | Oct 6, 2000 |
| Publication date | Jun 2, 2020 |
| Grant date | Jun 2, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
This invention provides methods for attaching a nucleic acid to a solid surface and for sequencing nucleic acid by detecting the identity of each nucleotide analogue after the nucleotide analogue is incorporated into a growing strand of DNA in a polymerase reaction. The invention also provides nucleotide analogues which comprise unique labels attached to the nucleotide analogue through a cleavable linker, and a cleavable chemical group to cap the —OH group at the 3′-position of the deoxyribose.
Opening claim text (preview).
What is claimed is: 1. A deoxyribonucleic acid having attached by a phosphodiester bond at its 3′ end, a deoxyribonucleotide analogue having any one of the following structures: wherein the O α is the 0 atom at the 3′ end of the deoxyribonucleic acid, and the wavy line represents the remainder of the deoxyribonucleic acid that is 5′ relative to the O α atom; wherein R (a) represents a small, chemically cleavable, chemical group capping the oxygen at the 3′ position of the deoxyribose of the deoxyribonucleotide analogue, and (b) does not contain a ketone group; wherein OR is not a methoxy group, an ester group or an allyl ether group; wherein Tag represents a detectable fluorescent moiety; wherein Y represents a chemically cleavable, chemical linker; wherein the deoxyribonucleic acid: i) produces a 3′—OH group on the deoxyribose of the deoxyribonucleotide analogue upon cleavage of R, and ii) no longer includes a tag on the base upon cleavage of Y and wherein if the deoxyribonucleotide analogue is: (A), it is capable of forming hydrogen bonds with cytosine or a cytosine nucleotide analogue; (B), it is capable of forming hydrogen bonds with thymine or a thymine nucleotide analogue; (C), it is capable of forming hydrogen bonds with guanine or a guanine nucleotide analogue; or (D), it is capable of forming hydrogen bonds with adenine or an adenine nucleotide analogue. 2. The deoxyribonucleic acid of claim 1 , wherein the allyl ether group is O—CH 2 CH═CH 2 .
involving nucleic acid arrays, e.g. sequencing by hybridisation · CPC title
incorporating a non-extendable or blocking moiety · CPC title
Pyrrolo-pyrimidine radicals · CPC title
Polymerase chain reaction [PCR] · CPC title
Sanger sequencing method, i.e. oligonucleotide sequencing using primer elongation and dideoxynucleotides as chain terminators · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.